X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
humans (13) 13
male (9) 9
female (7) 7
aged (6) 6
article (6) 6
middle aged (6) 6
animals (5) 5
autophagy (5) 5
diabetes (5) 5
obesity (4) 4
obesity - complications (4) 4
obesity - therapy (4) 4
overweight - therapy (4) 4
abridged index medicus (3) 3
adult (3) 3
blood pressure (3) 3
caloric restriction (3) 3
care and treatment (3) 3
diabetes mellitus, type 2 - complications (3) 3
diabetes mellitus, type 2 - therapy (3) 3
endocrinology & metabolism (3) 3
energy-metabolism (3) 3
fatty liver (3) 3
fgf21 (3) 3
glucose transport proteins, facilitative - genetics (3) 3
hiv infections - prevention & control (3) 3
intervention (3) 3
mice (3) 3
original (3) 3
overweight - complications (3) 3
patients (3) 3
signal transduction (3) 3
type 2 diabetes (3) 3
weight-loss (3) 3
aged, 80 and over (2) 2
amp-activated protein kinases - metabolism (2) 2
ampk (2) 2
analysis (2) 2
animal models (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
biology (2) 2
breast cancer (2) 2
camptothecin - administration & dosage (2) 2
camptothecin - adverse effects (2) 2
camptothecin - analogs & derivatives (2) 2
cancer (2) 2
cardiovascular-disease (2) 2
cd8-positive t-lymphocytes - immunology (2) 2
cell biology (2) 2
clinical neurology (2) 2
clinical pharmacokinetics (2) 2
clinical trials (2) 2
diet (2) 2
environmental sciences (2) 2
follow-up studies (2) 2
gastroenterology and hepatology (2) 2
genetic variation (2) 2
genome, viral - genetics (2) 2
genome-wide association study (2) 2
genomic structural variation (2) 2
glucose transport proteins, facilitative - metabolism (2) 2
glucose transporters (2) 2
health (2) 2
hepatocytes - metabolism (2) 2
hiv infections - immunology (2) 2
hiv infections - virology (2) 2
hiv-1 - genetics (2) 2
hiv-1 - immunology (2) 2
hiv-1 - pathogenicity (2) 2
immune evasion - genetics (2) 2
immune evasion - immunology (2) 2
immunity (2) 2
immunoconjugates - administration & dosage (2) 2
immunoconjugates - adverse effects (2) 2
immunology (2) 2
infection (2) 2
infectious diseases (2) 2
insulin (2) 2
irinotecan (2) 2
life style (2) 2
lifestyle intervention (2) 2
liver (2) 2
management (2) 2
medicine (2) 2
medicine & public health (2) 2
metabolism (2) 2
mice, knockout (2) 2
mortality (2) 2
motion pictures (2) 2
motor activity (2) 2
multidisciplinary sciences (2) 2
nutrition & dietetics (2) 2
obesity - metabolism (2) 2
oligonucleotide array sequence analysis (2) 2
oncology (2) 2
original article (2) 2
patient education as topic (2) 2
pgc-1-alpha (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Endocrinology, ISSN 0013-7227, 05/2018, Volume 159, Issue 5, pp. 2110 - 2126
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 4, pp. S715 - S715
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2016, Volume 6, Issue 1, p. 38586
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 04/2019, Volume 10, Issue 1, pp. 1587 - 16
Journal Article
Autophagy, ISSN 1554-8627, 11/2018, Volume 14, Issue 11, pp. 1959 - 1975
The macroautophagy/autophagy-inducing disaccharide, trehalose, has been proposed to be a promising therapeutic agent against neurodegenerative and... 
glucose transport | ectopic P-granules autophagy protein | solute carrier 2A | transcription factor EB | fibroblast growth factor | Beclin 1 | PPAR-ALPHA | LIPID-METABOLISM | PGC-1-ALPHA | HEPATIC FGF21 EXPRESSION | AUTOPHAGY | CELL BIOLOGY | DIET | AMPK | DEGRADATION | EPG5 | ENERGY-METABOLISM
Journal Article
JCI insight, ISSN 2379-3708, 08/2018, Volume 3, Issue 16
The hepatic glucose fasting response is gaining traction as a therapeutic pathway to enhance hepatic and whole-host metabolism. However, the mechanisms... 
Signal transduction | Diabetes | Metabolism | Hepatology | Insulin signaling | MEDICINE, RESEARCH & EXPERIMENTAL | LIPOXYGENASES | ANALOGS | CALORIC RESTRICTION | FATTY LIVER | GLUT8 | GENE-THERAPY | DIFFERENTIATION | ENERGY-METABOLISM | MOLECULAR-MECHANISMS | FGF21
Journal Article
PLoS Pathogens, ISSN 1553-7366, 03/2012, Volume 8, Issue 3, p. e1002529
Journal Article
by Al-Shahi Salman, Rustam and Frantzias, Joseph and Lee, Robert J and Lyden, Patrick D and Battey, Thomas W K and Ayres, Alison M and Goldstein, Joshua N and Mayer, Stephan A and Steiner, Thorsten and Wang, Xia and Arima, Hisatomi and Hasegawa, Hitoshi and Oishi, Makoto and Godoy, Daniel A and Masotti, Luca and Dowlatshahi, Dar and Rodriguez-Luna, David and Molina, Carlos A and Jang, Dong-Kyu and Davalos, Antonio and Castillo, José and Yao, Xiaoying and Claassen, Jan and Volbers, Bastian and Kazui, Seiji and Okada, Yasushi and Fujimoto, Shigeru and Toyoda, Kazunori and Li, Qi and Khoury, Jane and Delgado, Pilar and Sabín, José Álvarez and Hernández-Guillamon, Mar and Prats-Sánchez, Luis and Cai, Chunyan and Kate, Mahesh P and McCourt, Rebecca and Venkatasubramanian, Chitra and Diringer, Michael N and Ikeda, Yukio and Worthmann, Hans and Ziai, Wendy C and d'Esterre, Christopher D and Aviv, Richard I and Raab, Peter and Murai, Yasuo and Zazulia, Allyson R and Butcher, Kenneth S and Seyedsaadat, Seyed Mohammad and Grotta, James C and Martí-Fàbregas, Joan and Montaner, Joan and Broderick, Joseph and Yamamoto, Haruko and Staykov, Dimitre and Connolly, E Sander and Selim, Magdy and Leira, Rogelio and Moon, Byung Hoo and Demchuk, Andrew M and Di Napoli, Mario and Fujii, Yukihiko and Anderson, Craig S and Rosand, Jonathan and Hanley, Daniel F and Davis, Stephen and Gregson, Barbara and Lees, Kennedy R and Muir, Keith W and Xie, Peng and Bakhshayesh, Babak and McDonald, Mark and Brott, Thomas and Pennati, Paolo and Parry-Jones, Adrian R and Smith, Craig J and Hopkins, Stephen J and Slevin, Mark and Campi, Veronica and Singh, Puneetpal and Papa, Francesca and Popa-Wagner, Aurel and Tudorica, Valeria and Takagi, Ryo and Teramoto, Akira and Weissenborn, Karin and Lanfermann, Heinrich and ICH Growth Individual Patient Data Meta-analysis Collaborators and VISTA-ICH Collaboration
The Lancet Neurology, ISSN 1474-4422, 10/2018, Volume 17, Issue 10, pp. 885 - 894
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 19, pp. 3843 - 3854
BACKGROUND Sacituzumab govitecan (IMMU‐132), an antitrophoblastic cell‐surface antigen (anti‐Trop‐2) humanized antibody‐SN‐38 conjugate, had encouraging... 
clinical trial | trophoblastic cell‐surface antigen (Trop‐2) | epithelial cancers | antibody‐drug conjugate | IMMU‐132 (sacituzumab govitecan) | SN‐38 | trophoblastic cell-surface antigen (Trop-2) | SN-38 | antibody-drug conjugate | IMMU-132 (sacituzumab govitecan) | METABOLITES | SOLID TUMORS | ETIRINOTECAN PEGOL NKTR-102 | CLINICAL PHARMACOKINETICS | BREAST-CANCER | EZN-2208 | ONCOLOGY | COLORECTAL-CANCER | THERAPEUTIC TARGET | IRINOTECAN | trophoblastic cellsurface antigen (Trop-2) | Neoplasms - metabolism | Humans | Middle Aged | Half-Life | Immunoconjugates - pharmacokinetics | Male | Response Evaluation Criteria in Solid Tumors | Immunoconjugates - administration & dosage | Glucuronosyltransferase - genetics | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Antibodies, Monoclonal, Humanized - pharmacokinetics | Camptothecin - blood | Aged, 80 and over | Antigens, Neoplasm - metabolism | Adult | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Antineoplastic Agents, Phytogenic - pharmacokinetics | Antineoplastic Agents, Phytogenic - adverse effects | Camptothecin - analogs & derivatives | Immunoconjugates - adverse effects | Camptothecin - pharmacokinetics | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Cell Adhesion Molecules - metabolism | Neoplasms - drug therapy | Irinotecan | Aged | Immunoglobulin G - metabolism | Usage | Care and treatment | Safety and security measures | Analysis | Epithelial tumors | Pharmacokinetics | Antibody-drug conjugates | Camptothecin | Antigens | Toxicity | Immunoglobulin G | Radioactive half-life | Breast cancer | Pharmacology | Metastasis | Criteria | Patients | Cell surface | Metastases | Uridine | Safety | Solid tumors | Drug dosages | Cancer | Tumors | Half life | Neutropenia | Glucuronosyltransferase | Index Medicus | Abridged Index Medicus
Journal Article